Bausch Health Companies Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Bausch Health Companies Inc. (BHC) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $60.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-02-19
- Bausch Health Companies Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $60.00M, a 30.23% decline from fiscal 2024.
- Bausch Health Companies Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $86.00M, a 218.52% increase from fiscal 2023.
- Bausch Health Companies Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $27.00M.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|
| 2025-12-31 | $60.00M 10-K · filed 2026-02-19 | |
| 2024-12-31 | $86.00M 10-K · filed 2026-02-19 | |
| 2023-12-31 | $27.00M 10-K · filed 2026-02-19 | |
| 2019-12-31 | $282.00M 8-K · filed 2021-05-04 | |
| 2019-01-01 | $282.00M 10-Q · filed 2019-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |